700832-44-6

Basic information

• Product Name: 3'-[4-Benzyloxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane
• Synonyms: 3'-[4-Benzyloxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane
• CAS NO: 700832-44-6
• Molecular Weight: 458.641
• Mol File: 700832-44-6.mol

Chemical Properties

• CAS DataBase Reference: 3'-[4-Benzyloxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-[4-Benzyloxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane(700832-44-6)
• EPA Substance Registry System: 3'-[4-Benzyloxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane(700832-44-6)

Safety Data

• Hazardous Substances Data: 700832-44-6(Hazardous Substances Data)

Upstream product

• 700832-43-5 3'-[4-benzyloxy-3-methylphenyl]-3'-[4-trifluoromethylsulfonyloxy-3-methylphenyl]pentane 
• 193065-68-8 (3-ethoxy-3-oxopropyl)zinc(II) bromide 

Downstream Products

• 700832-46-8 3'-[4-hydroxy-3-methylphenyl]-3'-[4-(2-ethoxycarbonylethyl)-3-methylphenyl]pentane 

Relevant articles and documents

Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators

The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, diphenyl compound with vitamin D receptor (VDR) modulating activity.

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1a,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.